News News
Your current location:
Homepage
>
>
>
The second phase of Lepu Pharmaceutical Technology's annual output of 1.5 billion (tablets, granules) solid preparation technological transformation project passed the safety completion acceptance

The second phase of Lepu Pharmaceutical Technology's annual output of 1.5 billion (tablets, granules) solid preparation technological transformation project passed the safety completion acceptance

  • Categories:Company News
  • Time of issue:2020-11-17 14:19
  • Views:

(Summary description)In order to accelerate the legalization and normalization of the second phase of the technical transformation project for solid preparations with an annual output of 1.5 billion (tablets, granules), according to relevant regulations

The second phase of Lepu Pharmaceutical Technology's annual output of 1.5 billion (tablets, granules) solid preparation technological transformation project passed the safety completion acceptance

(Summary description)In order to accelerate the legalization and normalization of the second phase of the technical transformation project for solid preparations with an annual output of 1.5 billion (tablets, granules), according to relevant regulations

  • Categories:Company News
  • Time of issue:2020-11-17 14:19
  • Views:
Information

In order to accelerate the legalization and normalization of the second phase of the technical transformation project for solid preparations with an annual output of 1.5 billion (tablets, granules), according to relevant regulations, on October 13, 2020, Lepu Pharmaceutical Technology organized the acceptance of the technical transformation project At the review meeting, the acceptance expert group carefully checked the relevant materials, checked the production site, considered that the acceptance conditions were met, and agreed that the project passed the completion acceptance and can be legally produced.

The second phase of Lepu Pharmaceutical Technology's annual output of 1.5 billion (tablets, granules) solid preparation technological transformation project, entrusted Zhejiang Pharmaceutical Industry Design Institute to design, and organize the installation and construction and equipment installation and commissioning according to the content of the facility design section. After completion, the degree of automation has been greatly improved, and the output and per capita efficiency have been greatly improved.

Keyword:

Scan the QR code to read on your phone

11-17

Zhejiang Lepu Pharmaceutical Co., Ltd. signed an agreement with the Taizhou Research Institute of SUSTech to build a joint R&D center

On October 12, 2020, Zhejiang Lepu Pharmaceutical, Southern University of Science and Technology Taizhou Research Institute and Taizhou Aisente Technology Co., Ltd. held a joint R&D center signing ceremony in Zhejiang Lepu Pharmaceutical Co., Ltd. Ai Jianqi, Dean of Taizhou Research Institute of Southern University of Science and Technology, General Manager of Taizhou Ascent Technology Co., Ltd., Doctoral Supervisor Professor Zhang Xumu, and General Manager Hong Huabin of Zhejiang Lepu Pharmaceutical Co., Ltd. attended the signing ceremony.
11-17

Zhejiang Lepu Pharmaceutical starts weekly learning meetings

In order to accelerate the legalization and normalization of the second phase of the technical transformation project for solid preparations with an annual output of 1.5 billion (tablets, granules), according to relevant regulations, on October 13, 2020
11-17

The second phase of Lepu Pharmaceutical Technology's annual output of 1.5 billion (tablets, granules) solid preparation technological transformation project passed the safety completion acceptance

In order to accelerate the legalization and normalization of the second phase of the technical transformation project for solid preparations with an annual output of 1.5 billion (tablets, granules), according to relevant regulations
11-17

Shen Yinchu, academician of the Chinese Academy of Engineering, came to Zhejiang Lepu to guide scientific research

On September 30th, Shen Yinchu, academician of the Chinese Academy of Engineering, and his entourage came to our company to guide scientific research work. After visiting the company's exhibition hall and preparation production workshop
11-17

Zhejiang Lepu Pharmaceutical organizes party members to attend party classes

On August 21, Zhejiang Lepu Pharmaceutical organized more than 50 middle and high-level party members of the company to attend party classes. General Manager Hong Huabin gave a profound party lesson to party members and cadres at the meeting.
11-17

Leaders of Zhejiang Food and Drug Administration investigate Zhejiang Lepu Pharmaceutical

On September 17, Shao Yuanchang, deputy director of Zhejiang Provincial Drug Administration, accompanied by leaders of the two-level market supervision administration of Taizhou City, went to Zhejiang Lepu Pharmaceutical to conduct the "three services" of serving enterprises, serving the masses, and serving the grassroots. Research work.
Previous page
1
2
这是描述信息

Support Hotline

QR code

Scan to enter

Copyright © 2021 Zhejiang LePu Pharmaceutical Co., Ltd. All rights reserved 浙ICP备17026965号 Powered by www.300.cn